Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
52 studies found for:    physical | urticaria
Show Display Options
Rank Status Study
21 Completed Study on Mastocytosis for Rupatadine Treatment
Condition: Mastocytosis
Intervention: Drug: Rupatadin
22 Completed A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)
Conditions: Urticaria;   Chronic Idiopathic Urticaria
Intervention: Drug: desloratadine
23 Completed Phase II Solar Urticaria (SU) Pilot Study
Condition: Solar Urticaria
Intervention: Drug: afamelanotide
24 Not yet recruiting Efficacy and Safety of Omalizumab in Patients With Severe Acute Urticaria
Condition: Urticaria
Intervention: Drug: omalizumab
25 Recruiting Cold Contact Urticaria Treatment With Rilonacept
Condition: Cold Contact Urticaria
Interventions: Drug: Rilonacept;   Drug: Placebo
26 Recruiting Bilastine Updosing in Chronic Spontaneous Urticaria
Condition: Chronic Urticaria
Interventions: Drug: Bilastine;   Drug: Bilastin
27 Completed Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria
Condition: Urticaria
Intervention: Drug: Alesion®
28 Recruiting Study of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, CRMO, Still's Disease, Behcet's Disease, and Other Undifferentiated Autoinflammatory Diseases)
Conditions: Urticaria;   Arthropathy;   Lymphadenopathy;   Nervous System Anomalies
Intervention:
29 Suspended Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease
Conditions: Nervous System Malformations;   Arthropathy, Neurogenic;   Urticaria;   Papilledema
Intervention:
30 Completed
Has Results
Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
Conditions: Familial Cold Autoinflammatory Syndrome (FCAS);   Familial Cold Urticaria;   Muckle-Wells Syndrome (MWS);   Genetic Diseases, Inborn
Interventions: Drug: rilonacept 160 mg;   Drug: Placebo
31 Not yet recruiting Hereditary AngioEdema, Neurobiology and Psychopathology
Conditions: Hereditary AngioEdema;   Anxiety;   Depression
Intervention: Other: Clinical and psychopathological assessment of HAE patients
32 Completed
Has Results
Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema
Condition: Hereditary Angioedema
Intervention: Drug: ecallantide
33 Recruiting Study of Factors Regulating Mast Cell Proliferation
Condition: Mastocytosis
Intervention:
34 Completed Cause and Natural Course of Pediatric-Onset Mastocytosis
Condition: Mastocytosis
Intervention:
35 Completed
Has Results
Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Intervention: Drug: ecallantide
36 Recruiting Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Condition: Hereditary Angioedema
Intervention: Drug: rhC1INH
37 Terminated Effectiveness of Bradykinin Receptor Blocker at Reducing Swelling Associated With Angiotensin Converting Enzyme (ACE) Inhibitor-Associated Angioedema
Condition: Angioneurotic Edema
Interventions: Drug: HOE-140;   Other: Placebo
38 Completed Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing
Conditions: Mastocytosis;   Anaphylaxis
Intervention:
39 Completed Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers
Condition: Hereditary Angioedema (HAE)
Intervention: Drug: Icatibant (30 mg)
40 Completed A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161
Condition: Hereditary Angioedema
Intervention: Drug: BCX4161

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-52) Show next page of results    Last Page
Indicates status has not been verified in more than two years